Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Rizzieri

Showing results (1-10 of 132) with videos related to

Pageof 14
Sort By:
Blood|December 18, 2012
MDS: unraveling the mysteryDavid A Rizzieri
Clinical Advances in Hematology & Oncology : H&O|March 10, 2012
Chemoimmunotherapy's potential to impact paroxysmal nocturnal hemoglobinuriaDavid A Rizzieri, Katherine Walsh
Hematology. American Society of Hematology. Education Program|December 4, 2016
Treatment of blastic plasmacytoid dendritic cell neoplasmJill M Sullivan, David A Rizzieri
Therapeutic Advances in Hematology|December 4, 2014
Clinical potential of elacytarabine in patients with acute myeloid leukemiaLindsay A M Rein, David A Rizzieri
Clinical Medicine & Research|September 15, 2005
Radioimmunotherapy for Non-Hodgkin's LymphomaArati V Rao, Gamal Akabani, David A Rizzieri
Current Oncology Reports|July 6, 2010
Haploidentical transplantation for leukemiaJunya Kanda, Nelson J Chao, David A Rizzieri
International Journal of Hematology|March 4, 2011
Alemtuzumab for the prevention and treatment of graft-versus-host diseaseJunya Kanda, Richard D Lopez, David A Rizzieri
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 24, 2007
Allogeneic hematopoietic stem cell transplant using mismatched/haploidentical donorsLiang-Piu Koh, David A Rizzieri, Nelson J Chao
International Journal of Hematologic Oncology|December 5, 2013
New approaches to manipulate minimal residual disease after allogeneic stem cell transplantationLindsay Am Rein, Anthony D Sung, David A Rizzieri
Leukemia & Lymphoma|May 10, 2002
CD52 expression in mantle cell lymphomaAdam J Bass, Jerald Gong, Ramona Nelson, et al.
Pageof 14

Showing results (1-10 of 132) with videos related to

Sort By:
Pageof 14
Blood|December 18, 2012
MDS: unraveling the mysteryDavid A Rizzieri
Clinical Advances in Hematology & Oncology : H&O|March 10, 2012
Chemoimmunotherapy's potential to impact paroxysmal nocturnal hemoglobinuriaDavid A Rizzieri, Katherine Walsh
Hematology. American Society of Hematology. Education Program|December 4, 2016
Treatment of blastic plasmacytoid dendritic cell neoplasmJill M Sullivan, David A Rizzieri
Therapeutic Advances in Hematology|December 4, 2014
Clinical potential of elacytarabine in patients with acute myeloid leukemiaLindsay A M Rein, David A Rizzieri
Clinical Medicine & Research|September 15, 2005
Radioimmunotherapy for Non-Hodgkin's LymphomaArati V Rao, Gamal Akabani, David A Rizzieri
Current Oncology Reports|July 6, 2010
Haploidentical transplantation for leukemiaJunya Kanda, Nelson J Chao, David A Rizzieri
International Journal of Hematology|March 4, 2011
Alemtuzumab for the prevention and treatment of graft-versus-host diseaseJunya Kanda, Richard D Lopez, David A Rizzieri
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 24, 2007
Allogeneic hematopoietic stem cell transplant using mismatched/haploidentical donorsLiang-Piu Koh, David A Rizzieri, Nelson J Chao
International Journal of Hematologic Oncology|December 5, 2013
New approaches to manipulate minimal residual disease after allogeneic stem cell transplantationLindsay Am Rein, Anthony D Sung, David A Rizzieri
Leukemia & Lymphoma|May 10, 2002
CD52 expression in mantle cell lymphomaAdam J Bass, Jerald Gong, Ramona Nelson, et al.
Pageof 14